Frequency, Timing, and Predictors of Palliative Care Consultation in Patients with Advanced Cancer at a Tertiary Cancer Center: Secondary Analysis of Routinely Collected Health Data

Watanabe, Sharon; Faily, Viane; Mawani, Asifa; Huot, Ann; Tarumi, Yoko; Potapov, Alexey; Fassbender, Konrad; Fairchild, Alysa; Joy, Anil A.; King, Karen; Roa, Wilson; Venner, Christopher P.; Baracos, Vickie E.

doi:10.1634/theoncologist.2019-0384

Cited by 7 publications

(9 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is increasing evidence to suggest that PC access depends on patients’ sociodemographic and medical characteristics [ 13 , 14 , 32 , 43 – 47 ]. The results from the present study support this.…”

Section: Discussionmentioning

confidence: 99%

Access to inpatient palliative care among cancer patients in France: an analysis based on the national cancer cohort

Janah

Bihan-Benjamin

Mancini

et al. 2020

BMC Health Serv Res

View full text Add to dashboard Cite

Background Closely linked to the concept of supportive care, the integrated model of palliative care (PC) implies identifying, assessing and treating physical and psychological suffering as early as needed, irrespective of patient characteristics. In France, as in the most southern European countries, little is known about the proportion of cancer patients who have access to PC. Accordingly, we aimed in this study to estimate the proportion of cancer patients in France who have access to inpatient PC, and to explore associated factors. We carried out a nationwide retrospective cohort study using data from the French national health system database (SNDS) for all individuals diagnosed with cancer in 2013 and followed between 2013 and 2016. We compared patients who had inpatient PC with those who did not. Results Of the 313,059 cancer patients included in the national French cancer cohort in 2013, 53,437 (17%) accessed inpatient PC at least once between 2013 and 2016, ranging from 2% in survivors to 56% in the deceased population. Multivariate logistic regression revealed that women and younger patients (18–49 years old) were less likely to access inpatient PC while patients with a greater number of comorbidities, metastatic cancer, or cancer of the nervous system, were more likely to have done so. Conclusions A negligible proportion of cancer survivors accessed inpatient PC. More research and training are needed to convince healthcare providers, patients, and families about the substantial benefits of PC, and to promote better integration of PC and oncology.

show abstract

Section: Discussionmentioning

confidence: 99%

Access to inpatient palliative care among cancer patients in France: an analysis based on the national cancer cohort

Janah

Bihan-Benjamin

Mancini

et al. 2020

BMC Health Serv Res

View full text Add to dashboard Cite

show abstract

“…Many studies have demonstrated the effectiveness of early SPC involvement and integrating oncology and palliative care, based on patient reported outcomes, such as better quality of life, end of life care delivery, communication, symptom and mood management, preventing depressive symptoms, receiving aggressive end of life care, satisfaction with care, and longer survival time [ those who reported "referral after cancer treatment," and 50.4% of those who reported "referral after cancer treatment" were "evaluated as late" after excluding the "none of these" responses. Furthermore, Watanabe et al reported that in a tertiary cancer center in Canada, the median time between SPC consultation and death was two months [33]. Although SPC clinical activities in Japan have become more popular, medical practitioners should continue improving SPC access at any time to make it more convenient for cancer patients and their families even if they are newly diagnosed with advanced or incurable cancer or are receiving anti-cancer treatment.…”

Section: Discussionmentioning

confidence: 99%

Appropriate referral timing to specialized palliative care service: survey of bereaved families of cancer patients who died in palliative care units

Tagami

Masukawa

Inoue

et al. 2021

Support Care Cancer

View full text Add to dashboard Cite

“…GDIsc or ed ⇔ erencesbetweenparticipantswhoresponded, "referralatdiagnosis or dur ∈ gcancertreatment" and "ref those who reported "referral after cancer treatment," and 50.4% of those who reported "referral after cancer treatment" were "evaluated as late" after excluding the "none of these" responses. Furthermore, Watanabe et al reported that in a tertiary cancer center in Canada, the median time between SPC consultation and death was two months [33]. Although SPC clinical activities in Japan have become more popular, medical practitioners should continue improving SPC access at any time to make it more convenient for cancer patients and their families even if they are newly diagnosed with advanced or incurable cancer or are receiving anti-cancer treatment.…”

Section: Discussionmentioning

confidence: 99%

Appropriate Referral Timing To Specialized Palliative Care Service: Survey of Bereaved Families of Cancer Patients Who Died in Palliative Care Units

Tagami

Masukawa

Inoue

et al. 2021

Preprint

View full text Add to dashboard Cite

Few studies have investigated appropriate referral timing of specialized palliative care (SPC) from the perspective of cancer patients’ and families’ experiences. We aimed to clarify appropriate SPC referral timing for patients with advanced cancer and their families. We used data from a nationwide bereaved family survey in Japan. We sent a questionnaire to 999 bereaved families of cancer patients who died in 164 palliative care units (PCUs) and analyzed the first SPC referral timing and how patients evaluated it. We defined SPC as outpatient or inpatient palliative care service comprising certified palliative care physicians, advanced-practice nurses, and multidisciplinary practitioners. Finally, 51.6% (n = 515) of all responses were analyzed. The SPC referral timing was evaluated as appropriate (26.1%), late or too late (20.2%), early or too early (1.2%), and none of these (52.5%). Of these, 32.3% reported that they were referred to an SPC when diagnosed with advanced or incurable cancer or during anti-cancer treatment, and 62.6% reported they were referred after anti-cancer treatment. Patient-perceived appropriateness of SPC referral timing was associated with their good death process. After excluding “none of these” responses, a significantly higher proportion of respondents who reported being referred to SPC at diagnosis and during anti-cancer treatment evaluated the response timing as appropriate, compared to those who reported being referred after anti-cancer treatment. Appropriate timing for SPC referrals relates to quality of death; findings suggest that appropriate timing is at the time of diagnosis or during anti-cancer treatment.

show abstract

Frequency, Timing, and Predictors of Palliative Care Consultation in Patients with Advanced Cancer at a Tertiary Cancer Center: Secondary Analysis of Routinely Collected Health Data

Cited by 7 publications

References 23 publications

Access to inpatient palliative care among cancer patients in France: an analysis based on the national cancer cohort

Access to inpatient palliative care among cancer patients in France: an analysis based on the national cancer cohort

Appropriate referral timing to specialized palliative care service: survey of bereaved families of cancer patients who died in palliative care units

Appropriate Referral Timing To Specialized Palliative Care Service: Survey of Bereaved Families of Cancer Patients Who Died in Palliative Care Units

Contact Info

Product

Resources

About